How do palliative care doctors recognise imminently dying patients? A judgement analysis. by White, N et al.
1White N, et al. BMJ Open 2018;8:e024996. doi:10.1136/bmjopen-2018-024996
Open access 
How do palliative care doctors recognise 
imminently dying patients? A judgement 
analysis
Nicola White,1 Priscilla Harries,2,3 Adam JL Harris,4 Victoria Vickerstaff,1 
Philip Lodge,5 Catherine McGowan,6 Ollie Minton,7 Christopher Tomlinson,8 
Adrian Tookman,5 Fiona Reid,9 Patrick Stone1
To cite: White N, Harries P, 
Harris AJL, et al.  How do 
palliative care doctors recognise 
imminently dying patients? A 
judgement analysis. BMJ Open 
2018;8:e024996. doi:10.1136/
bmjopen-2018-024996
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2018- 
024996).
Received 25 June 2018
Revised 4 October 2018
Accepted 19 October 2018
For numbered affiliations see 
end of article.
Correspondence to
Dr Nicola White;  
 n. g. white@ ucl. ac. uk
Research
© Author(s) (or their 
employer(s)) 2018. Re-use 
permitted under CC BY-NC. No 
commercial re-use. See rights 
and permissions. Published by 
BMJ.
AbstrACt
Objectives To identify a group of palliative care doctors 
who perform well on a prognostic test and to understand 
how they make their survival predictions.
Design Prospective observational study and two cross-
sectional online studies.
setting Phase I: an online prognostic test, developed 
from a prospective observational study of patients referred 
to palliative care. Phase II: an online judgement task 
consisting of 50 hypothetical vignettes.
Participants All members of the Association of Palliative 
Medicine (APM) were eligible (n=~1100). 99 doctors 
completed the prognostic test and were included in the 
phase I analysis. The top 20% were invited to participate in 
phase II; 14/19 doctors completed the judgement task and 
were included in the phase II analysis.
Measures Phase I: participants were asked to give a 
probability of death within 72 hours (0%–100%) for all 
20 cases. Accuracy on the prognostic test was measured 
with the Brier score which was used to identify the ‘expert’ 
group (scale range: 0 (expert)–1 (non-expert)). Phase II: 
participants gave a probability of death within 72 hours 
(0%–100%). A mixed model regression analysis was 
completed using the percentage estimate as the outcome 
and the patient information included in the vignettes as the 
predictors.
results The mean Brier score of all participants was 
0.237 (95% CI 0.235 to 0.239). The mean Brier score of 
the ‘experts’ was 0.184 (95% CI 0.176 to 0.192). Six of 
the seven prognostic variables included in the hypothetical 
vignettes were significantly associated with clinician 
predictions of death. The Palliative Performance Score 
was identified as being the most influential in the doctors’ 
prognostic decision making (β=0.48, p<0.001).
Conclusions This study identified six clinical signs and 
symptoms which influenced the judgement policies of 
palliative care doctors. These results may be used to teach 
novice doctors how to improve their prognostic skills.
bACkgrOunD
The Liverpool Care Pathway (LCP) was a 
care plan developed to improve care at the 
end of life. It was withdrawn from use in the 
UK following criticism from some members 
of the public, healthcare professionals and 
the media. One of the concerns expressed 
was that the recognition of imminent death 
was often inaccurate1–3 and therefore some 
people were being inappropriately regarded 
as being in the terminal phase of their illness 
when they were not in fact ‘imminently’ 
dying. Following withdrawal of the LCP, the 
National Institute for Health and Care Excel-
lence (NICE) published a clinical guideline, 
‘Care of dying adults in the last days of life’ 
(2015). The guidance began by advising 
clinicians what to do if, ‘it is thought that a 
person may be entering the last days of life’. 
However, although this important first step in 
the process relies on clinical judgement, the 
guideline itself provided no advice about how 
clinicians should develop or hone their prog-
nostic instincts.
Clinical judgement is subjective and as such 
it is difficult to investigate. Experts are often 
strengths and limitations of this study
 ► The methodology adopted in this study enabled a 
direct comparison between the accuracy of different 
doctors’ estimates of imminent death; this has not 
been done before.
 ► The approach that was taken in this study to quanti-
fy and objectively measure the ability of the ‘expert’ 
group was significantly more thorough than any-
thing which has been done before and is preferable 
to simply assuming that years of experience or se-
niority are synonymous with expertise.
 ► Judgement analysis offers a methodology to unpick 
clinical decision making, clinical intuition or ‘gut in-
stinct’, regarding how doctors recognise which pa-
tients are dying.
 ► The prognostic test may have lacked some face 
validity as the participants were not able to visual-
ly assess the patients. However, this lack of visual 
assessment was compensated for by the increased 
utility that arose from being able to compare numer-
ous different doctors’ performances on the same 
prognostic test.
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unable to articulate how their decisions are formulated.4 5 
This means that it would not be very informative to simply 
ask expert palliative care doctors how they recognise which 
patients are imminently dying. They are unlikely to have a 
clear insight into how they actually make prognostic deci-
sions and are more likely to simply report that they ‘just 
know’.4 Before being able to untangle the clinical skill of 
recognising the dying phase, it is necessary to establish 
a means of identifying which doctors, if any, are more 
accurate at prognosticating. It is usual in decision-making 
research to simply select experts on the basis of their 
seniority or years of experience.5–7 However, previous 
research has suggested that more experienced doctors 
are not necessarily the best prognosticators.8 9 Indeed, 
there is currently no objective mechanism for identifying 
which doctors are better prognosticators than others. We 
therefore decided to develop a prognostic test.
Once a group of experts has been identified, Social 
Judgement Theory offers a way to understand how 
these clinicians make decisions; using the ‘lens model’10 
adapted to a medical field.11 Figure 1 shows a visual repre-
sentation of this medical lens model. The left side of the 
lens model represents the ‘ecological validity’, which was 
defined as ‘the degree of correlation between the cues 
presented (patient information) and the event occurring 
(death)’.10 In the centre is the information presented 
(the cues) within the chosen environment (here, medical 
environment), and on the right hand side is the judges’ 
decision (the doctor’s judgement of the patient’s health). 
The ‘achievement arc’ is the relationship, or accuracy, 
between the doctor’s judgement and the patient event.
Judgement analysis aims to understand how decisions 
are made, this knowledge can then be shared with other 
people who might want to make decisions in a similar 
manner.10 12 13 The decision-making process (or judge-
ment) is analysed by asking experts to assess a series of 
cases, or vignettes, in which a number of factors (or cues) 
are presented at various levels of severity. Presenting infor-
mation in this manner allows the correlation between the 
various cues and the experts’ judgement to be statisti-
cally modelled. The different cues used by each expert 
and the relative weight given to each of those factors are 
referred to as that expert’s ‘judgement policy’.14 Judge-
ment analysis has previously been applied successfully 
in other healthcare settings such as in the diagnosis of a 
heart failure by general practitioners,15 in risk assessment 
of nurses16 and in driving recommendations of occupa-
tional therapists.12
Aim
The purpose of this study was to identify how palliative 
care doctors, who perform well on a prognostic test, make 
predictions about which patients are imminently dying.
The aim was achieved through the following objectives:
1. The identification of a group of doctors who perform 
well on a prognostic test of imminent death.
2. Modelling the prognostic decisions of this group to un-
derstand what information was most important for the 
identification of dying patients, in a second prognostic 
task.
MethOD
Overview
The study consisted of two distinct phases each involving 
separate prognostic tasks. In phase I, participants were 
invited to complete a prognostic test based on summa-
ries of real cases. In phase II, the best performers from 
the prognostic test were invited to complete a judgement 
analysis task consisting of a further 50 hypothetical case 
vignettes.
Participants
The participants for this study were all specialist pallia-
tive care doctors. These clinicians routinely work with 
people who are in the final days of life, and might be 
expected to have some special expertise at recognising 
imminent death. Eligible participants were members of 
the Association of Palliative Medicine (APM), which is 
the UK professional body for palliative care doctors. All 
members were invited to participate in the first phase 
(the prognostic test). They were contacted via an email 
through the association secretariat. At the end of phase I, 
the top performers on the prognostic task were invited to 
complete the second phase (judgement analysis).
Procedures
Phase I: test to identify the best prognosticators
No previous studies have attempted to objectively identify 
a group of prognosticators based on their performance 
(rather than on just their experience or training) and so 
it was necessary to develop a novel methodology. It would 
not have been adequate to simply identify doctors who 
are good at prognosticating based on a record of their 
own past performance, because most clinicians do not 
routinely record such data, and furthermore because any 
variations in performance may have been explained by 
differences in the case-mix of their patients. Nor would 
it have been practical to ask large numbers of geographi-
cally separated doctors to review the same patients and to 
Figure 1 The lens model adapted to a medical decision.11
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prospectively make estimates about their survival. There-
fore, the group of doctors with prognostic expertise were 
identified by selecting those doctors who performed best 
on an online prognostic test.
The prognostic test consisted of a series of 20 case 
studies, or ‘vignettes’, obtained by undertaking a prospec-
tive observational study of patients who had been referred 
to specialist palliative care services. Patients were assessed 
on one occasion and a record was made of whether or not 
they died within the subsequent 72 hours.
The clinical characteristics of each patient were 
summarised as a one page vignette. The aim was to 
provide information in a style that would be familiar 
to clinicians participating in a multidisciplinary team 
meeting. The structure of each vignette was standardised. 
In the first paragraph, there a general description of the 
patient and the circumstances that led to their admission. 
The second paragraph detailed the clinical condition on 
the day of admission and any changes since then. The 
final paragraph detailed the participant’s condition on 
the day of assessment. Additional information such as 
medications or recent blood tests were also presented, 
where they were available (see online supplementary file 
1 for an example vignette).
The prognostic test was open to recruitment between 
22 April 2016 and 1 July 2016. Doctors were asked for 
some demographic information and to read through 
each case and were asked to make a numerical prediction 
about whether or not each patient would die within the 
subsequent 72 hours (0% indicating no chance and 100% 
indicating certainty).
Phase II: judgement analysis task
The top performing doctors (identified in phase I) 
were asked to complete an additional prognostic deci-
sion-making task, between 15 September 2016 and 31 
October 2016. This task, which was similar in format to 
the prognostic test described above, required partici-
pants to estimate the probability (0% no chance–100% 
certain) of death within the next 72 hours for 50 vignettes 
describing fictional palliative care patients. The fictional 
nature of the cases included was necessary in order to 
allow the content of the vignettes to be statistically manip-
ulated. This enabled the investigation of the relationship 
between the clinicians’ estimates and the putative prog-
nostic factors.
sample size
For each phase of this study, consideration was given to 
both the number of vignettes included in the online tasks 
and to the number of doctors participating.
Phase I
The aim of the prognostic test was to identify the top 
performers in terms of prognostic accuracy. Increasing 
the number of vignettes would increase the ability of 
the test to discriminate between respondents but would 
add to the study burden for the participants. Piloting of 
the test, established that with 20 vignettes the test would 
take approximately 1 hour to complete. It was therefore 
considered that including >20 vignettes would increase 
the risk that the prognostic test would not be completed 
by respondents.
No previous studies had used this methodology to iden-
tify respondents with prognostic skills and we therefore 
had no previous data on which to base our participant 
sample size calculation. The sample size was determined 
by the membership of the APM and the number who 
responded to the invitation to participate.
Phase II
The sample size for the judgement analysis task was not 
determined a priori. Instead, we examined the results of 
the prognostic test to see if a ‘natural’ group of experts 
emerged (ie, whether the data revealed a subgroup of 
doctors who were clearly superior in terms of prognostic 
abilities).
Factors
According to a standard judgement analysis methodolog-
ical approach, each factor (piece of information about the 
patient) that is presented in a vignette requires between 
5 and 10 vignettes to determine the judgement policy 
of the individual.10 Thus, if one wished to investigate 
five prognostic factors it would be necessary to include 
between 25 and 50 vignettes in the judgement analysis 
task. In order to reduce the study burden on participants 
(and thereby minimise the risk of attrition), we decided 
to limit the total number of prognostic factors included in 
the judgement analysis task to seven. The factors included 
in the vignettes were selected on the basis of a review of 
the relevant literature,17–21 excluding factors that are 
not routinely collected in the final days of life (such as 
the results of blood tests) and then by asking specialist 
palliative care clinicians (four nurses and eight doctors) 
at two London hospital sites to rank the factors in order 
of importance. There is no accepted methodology to 
reduce the number of factors; however, this process is 
commonly used within judgement analysis to select which 
cues to include and has good face validity.12 22 The final 
list of prognostic factors included in the vignettes were: 
Cheyne-Stokes breathing; performance status (measured 
with the Palliative Performance Score (PPS)23); urinary 
output; level of sedation/agitation (measured with the 
Richmond Agitation and Sedation Scale (RASS)24); pres-
ence of noisy respiratory secretions; the speed at which 
the patient’s overall condition was deteriorating and 
peripheral cyanosis.
Vignettes
The vignettes in the judgement analysis task needed to 
span the range of severity of the different prognostic 
factors. However, with seven different factors, each with 
between two and seven levels it would have required 
an unmanageably large number of vignettes to include 
all of the possible scenarios as separate vignettes in the 
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prognostic test. Therefore, 50 vignettes were created 
and selected using a fractional factorial design (using 
IBM SPSS V.22.0 orthogonal design function). This 
approach allows for the creation of a subset of all of the 
possible vignettes within which the levels of each factor 
are presented enough times to allow for determination 
of the judgement policy of the participant.25 Finally, the 
vignettes were checked for face validity, meaning that any 
impossible cases were removed. For example, it would not 
be possible to have a patient with a PPS score of 70% but 
a RASS score of −5. Core information about each patient 
(the stem) was kept the same for all vignettes so that any 
changes in doctors’ survival estimates could be attributed 
to changes in the seven prognostic factors only. Figure 2 
shows an illustrative example of one of the vignettes used 
in the judgement analysis task.
statistical methods
For both phases of this study, participants with missing 
estimates were excluded from the analysis (complete case 
analysis). Rates of attrition have been reported.
Analysis of phase I (the prognostic test)
The survival estimates provided by the participants in the 
prognostic test were compared with the known outcomes 
for each case (ie, whether the patient died within 
72 hours). The accuracy of each doctor’s prognostic esti-
mate was determined by calculating the Brier score (BS).
The BS takes into account whether or not the predicted 
outcome occurred and the degree of certainty with which 
it was predicted. BS can range between 0 and 1 with a 
score of 0 representing perfect accuracy and a score of 1 
representing perfect inaccuracy. If a doctor had predicted 
a 50% probability of dying within 72 hours then regardless 
of whether or not the patient died, the BS would be 0.25 
(see online supplementary file 2 for further explanation). 
Therefore, a BS of 0.25 provides a useful benchmark 
when gauging the accuracy of doctors’ prognostic esti-
mates, because it can be obtained by consistently using a 
base-rate judgement (ie, always estimating the probability 
of death as 50%).
For each doctor who completed the test, the mean 
of their BS across the 20 vignettes was calculated, and 
this was used as a summary measure of the participant’s 
prognostic ability. Additional analyses were completed to 
assess the BS and demographic information.
Analysis of phase II (judgement analysis)
The seven prognostic factors in each of the vignettes were 
coded so that a higher score indicated a greater severity 
of that factor. The five binary variables were coded as 
either ‘absent=0’ or ‘present=1’, where presence of the 
factor always indicated a poorer outcome. For the RASS, 
which can vary between −5 (heavily sedated) and +4 
(highly agitated), the absolute value of the score was used, 
Figure 2 Example hypothetical case vignette used in the judgement analysis.
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resulting in a transformed 6-point scale ranging from 0 
(calm) to 5 (highly agitated/sedated). The PPS ranges 
from 0% (dead) to 100% (a healthy independent adult), 
however for the purposes of this study, the PPS scores 
were reduced to a 7-point scale ranging from 1 (equiva-
lent to PPS of 70% or more, representing a patient with 
little or no care needs) to 7 (equivalent to a PPS of 10%, 
representing a patient who is bedbound and needs full 
support).
The level of agreement between the experts was 
assessed using a two-way random effects model intraclass 
correlation coefficient (ICC). The judgement policy of 
the expert group was calculated by using a mixed model 
regression analysis, with the individual doctors’ estimate 
of the patient’s percentage probability of dying for each 
vignette as the dependent variable, the seven prognostic 
factors included in each vignette as predictor variables, 
and the doctor as a random effect. This analysis accounted 
for the hierarchical nature of the data (ie, the correlation 
of individual estimates by the same doctor). A postestima-
tion command of ‘esttab, beta’ was then applied to calcu-
late the standardised coefficients for comparison. This 
standardised coefficient identified how influential each 
factor was in the model, with a larger score indicating 
more influence. All analyses were performed using Stata 
V.13.
Patient involvement
Members of the South West London Cancer Research 
Network reviewed the protocol and the patient vignettes 
used in the prognostic test phase of the research.
results
Figure 3 presents an overview of the participants recruited 
in this study.
Phase I: the prognostic test
There were 166/1100 participants who responded to the 
invitation email (response rate of 15%). Out of the 166 
respondents, 99 completed all 20 questions (60%) and 
were included in the analysis. Table 1 shows the detail of 
the doctors who completed the prognostic test.
Overall, the mean BS of all participants was 0.237 
(95% CI 0.235 to 0.239). The mean BS of women was 
0.235 (95% CI 0.226 to 0.245) and this was not statisti-
cally significantly different (p=0.53) from the mean BS of 
men (0.241 (95% CI 0.226 to 0.257)). BS were not related 
to participants’ age (p=0.64), years qualified as a doctor 
(p=0.85) or years within palliative care (p=0.49).
We reviewed the distribution of the BS for the partici-
pants (figure 4) and based on this, decided that the top 
20% of performers (n=19) should be invited to participate 
Figure 3 Consolidated Standards of Reporting Trials diagram of recruitment.
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in the judgement analysis task. The mean BS of this group 
was 0.184 (95% CI 0.176 to 0.192), and their mean BS 
ranged from 0.136 to 0.199. Therefore, the scores of this 
group were clearly better than a base rate, or ‘random’ 
judgement, which would be indicated by BS=0.25.
Phase II: determining the judgement policy of the ‘expert’ 
group
Of the top 20% (n=19) of doctors invited to participate in 
the judgement analysis task, 14 agreed to do so (74%). All 
of the participating doctors were female and the majority 
were British (13/14). The mean age was 42 years (SD 6.5). 
The mean time since qualification was 17 years (SD 7.9). 
The mean time spent working within palliative care was 
10 years (SD 7.5). The frequency with which the partic-
ipants identified dying patients in their clinical practice 
was: daily (n=6), weekly (n=7) or monthly (n=1). There 
was moderate agreement between the doctors about the 
probability of imminent death for each of the patients 
described in the case vignettes (ICC=0.55; 95% CI 0.44 to 
0.66).
Judgement analysis
Table 2 shows the results from the mixed model analysis. 
It showed evidence that six prognostic variables were 
significantly related (p<0.001) to doctors’ predictions 
about the likelihood of imminent death.
The most influential factor in the doctors’ decision 
making was the PPS (table 2). The presence of Cheyne-
Stokes breathing was the next most influential factor. A 
decline in the patient’s overall condition and their level 
of agitation or sedation were the next most influential 
factors and had a similar level of influence. After these, 
the presence of noisy respiratory secretions and periph-
eral cyanosis had a similar level of influence on the model. 
A change in urinary output did not make a statistically 
significant difference to the doctors’ decision making.
DIsCussIOn
The aim of this research was to understand how doctors, 
with a measured prognostic ability, recognise when a 
patient is imminently dying. We found that for hospice 
inpatients with end-stage malignancy, the PPS was the most 
influential factor in doctors’ decision making, followed 
by the presence of Cheyne-Stokes breathing, decline in 
Table 1 Demographic information of all participants who 
completed the prognostic test
Excluded Included P values
Participants, n 67 99
Gender, n(%)
  Male 14 (22) 21 (21)
  Female 51 (78) 78 (79) 0.960
Age, mean (SD) 43.3 (11.3) 42.7 (9.5) 0.736
Ethnicity, n(%)
  White British 54 (81) 87 (88)
  Other 13 (19) 12 (12) 0.198
Years of experience, mean 
(SD)
18.5 (11.6) 17.5 (10.3) 0.564
Years within palliative care, 
mean (SD)
12.4 (9.1) 11.8 (8.4) 0.652
Number of test questions 
completed, median (IQR)
0 (0, 4)
Range 0–14
20 (20, 20)
Figure 4 Distribution of the mean Brier score for each doctor. The top 20% of performers, whose Brier scores were <0.2 
(dashed line) were invited to participate in the judgement analysis study (n=19).
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overall condition, level of agitation or sedation, presence 
of noisy respiratory secretions and peripheral cyanosis. 
This insight into the decision making of top prognostica-
tors could be used to develop teaching resources to help 
less experienced doctors to model their own judgement 
policies on those of the experts. Using our results as a 
guide, novices could be taught to hone their clinical intu-
ition by giving greater weight to certain factors (eg, PPS 
and presence of Cheyne-Stokes breathing) over other 
less important factors (eg, noisy respiratory secretions, 
peripheral cyanosis, urinary output). A similar approach 
to improving the decision-making abilities of novices 
by teaching them to model their judgement policies on 
those of experts has been shown to be successful in other 
(non-prognostic) situations and with other health and 
social care professionals.12 26 27
This research is important because, implicit in most clin-
ical guidelines and policies about end of life care, is the 
assumption that it is possible to recognise which patients 
are, or are not, imminently dying. The NICE guideline28 
on end-of-life care describes the recognition of immi-
nent death as an essential first step towards improving 
care for dying patients. However, the guideline does not 
clearly explain how doctors are expected to identify such 
patients, nor how novice doctors can be expected to learn 
or improve this clinical skill. It is noteworthy that in the 
prognostic test we developed, we found no discernible 
difference in the prognostic accuracy of doctors by age or 
seniority, suggesting that experience alone does not make 
a better prognosticator. The prognostic inaccuracies 
highlighted by previous reports1 2 29 may be a reflection of 
a lack of prognostic training (specifically in the recogni-
tion of the dying phase) in medical school curricula and 
in postgraduate medical training. The results from phase 
I of this study emphasise how challenging predicting 
dying is in clinical practice, suggesting that it is essential 
for doctors to learn how to make decisions under condi-
tions of uncertainty.
strengths and limitations
This is the first study to have objectively identified a group 
of doctors by comparing prognostic accuracy and to have 
investigated their judgement policies. This study has 
provided a novel insight into how palliative care doctors 
make prognostic decisions. It is noteworthy that this 
insight could not have been achieved by simply asking 
palliative care doctors to reflect on and explain how 
they predict which patients are imminently dying. This is 
because not every palliative care doctor is necessarily very 
good at predicting imminent death and second because 
clinical judgement is, by its nature, a subconscious ‘gut 
instinct’ developed from many years of experience that 
cannot easily be articulated by the doctors themselves.5 30
One potential limitation of this research was that the 
group identified as the top performers may not, in fact, 
have been genuine ‘experts’ and, with repeated testing, 
their performance may have demonstrated regression to 
the mean. Repeated testing of participants to demonstrate 
sustained levels of performance on the prognostic test was 
beyond the resources of the current study but could (and 
should) be undertaken before adopting the prognostic 
test as a genuine measure of performance. Nonetheless, 
the results shown in figure 4 did demonstrate an overall 
skew in favour of increased accuracy (BS<0.25), which 
lends support to the idea that the best performers really 
did have some expertise in this area. Even taking into 
consideration these limitations, the approach that was 
taken in this study to quantify and objectively measure the 
ability of the ‘expert’ group was significantly more thor-
ough than previous studies and is certainly preferable to 
assume that years of experience or seniority are synony-
mous with expertise.
Table 2 Expert group judgement policy
Prognostic factors
Regression 
coefficient* 95% CI P values
Standardised 
coefficient
PPS† 6.10 5.50 to 6.71 <0.001 0.48
Cheyne-Stokes Breathing‡ 15.39 13.07 to 17.71 <0.001 0.30
Decline in condition‡ 11.51 9.18 to 13.84 <0.001 0.23
Agitation or sedation (RASS)† 4.31 3.41 to 5.20 <0.001 0.23
Noisy respiratory secretions‡ 5.91 3.58 to 8.24 <0.001 0.12
Peripheral cyanosis‡ 5.40 3.09 to 7.71 <0.001 0.11
Urinary output‡ 0.39 −1.94 to 2.73 0.220 0.01
One of the experts in this phase of the study had also participated in the task of identifying which seven (out of a possible nine) prognostic 
factors to include in the judgement analysis task. As this individual was only one of 12 experts involved in deciding which factors to include, 
we did not consider that this was likely to have biased the results of the study. Nevertheless, a sensitivity analysis was undertaken in which 
the above analysis was repeated after excluding this participant, and this led to a very similar pattern of results (see online supplementary file 
3).
*Coefficient: the change in the percentage probability of death given the presence of the prognostic factor (if binary) or for a one unit increase 
in the prognostic factor (if continuous)
†Continuous variables, coded as integers: PPS 1 (≥70%) up to 7 (10%); RASS 0 (no agitation/sedation) up to 5 (heavily sedated/agitated).
‡Binary variables, coded as 0 (absent), 1 (present).
PPS, Palliative Performance Score; RASS, Richmond Agitation and Sedation Scale.
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Another limitation of the prognostic test was that it 
may have lacked ecological validity. Most doctors would 
prefer to review a patient face-to-face before making a 
prognostic estimate rather than relying on written clin-
ical summaries and laboratory results. However, the test 
was not completely divorced from the realities of clin-
ical practice, since doctors are often required to make 
prognostic decisions without the benefit of personally 
reviewing the patient (eg, when discussing patients at an 
MDT meeting or prioritising referrals to a service on the 
basis of information contained on referral forms). More-
over, the potential loss of ecological validity of the test 
was compensated for by the increased utility that arose 
from being able to compare numerous different doctors’ 
performances on the same prognostic test.
Similar issues about face validity may also be levelled 
at the judgement analysis task undertaken in phase II of 
the study. The orthogonal factorial design by which the 
factors were distributed across the vignettes may have 
led to the generation of some combinations that were 
less likely to be observed in the real world, where symp-
toms are more likely to ‘cluster’ together, or where one 
symptom might be a lot less common when found in the 
presence of another.
The response rate to the prognostic test was relatively 
low (15%) which could reduce the generalisability of the 
findings. However, it should be noted that the purpose of 
the test was not to obtain a ‘representative sample’, but to 
identify a group of experts.
Future research
It is important to emphasise that the judgement policy 
adopted by the doctors in this study was specific to the 
clinical scenario (the stem information) included in 
the judgement analysis task, that is, to predict imminent 
death (within 72 hours) among hospice inpatients with 
metastatic incurable cancer. The judgement policies of 
the doctors would almost certainly be different in other 
clinical circumstances. It is therefore important that our 
results are not extrapolated to other scenarios but are 
regarded as specific to the identification of imminent 
death among hospice inpatients with advanced cancer. 
To identify the best judgement policy in those situations 
would require further research using different partici-
pant groups and different case vignettes with the same 
methodology described in this study.
COnClusIOn
The results from this study has identified how specialist 
palliative care doctors, who performed well on a prog-
nostic test, weighted clinical information in order to make 
a decision about whether or not a patient was thought to 
be dying imminently. This information could be used to 
inform the development of educational training mate-
rials to teach novice doctors how and when to model their 
judgement policies on those of the prognostic experts.
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